Strive harnesses advanced reinforcement learning and real-time ICU data to deliver precise, personalized dosing recommendations for sepsis management, enhancing patient outcomes and reducing complications in critical care settings.

Company
Strive
Category
Real-Time Clinical Decision Support
Type
Fund I
Stage
Pre-Seed
Date
2025

About the company

Strive is a healthcare technology company dedicated to transforming critical care through its innovative reinforcement learning platform. Leveraging over 10 million hours of ICU data, Strive delivers real-time, personalized dosing recommendations for sepsis management, addressing a critical gap in clinical decision-making.

Founded by industry experts with deep clinical and technical experience, Strive integrates seamlessly into hospital workflows to improve patient outcomes and reduce complications. With strategic partnerships involving leading healthcare organizations such as Philips, Baxter, and the NHS via Palantir, Strive is well-positioned to drive a paradigm shift in precision medicine and elevate the standard of critical care.

Why We Invested

Effective sepsis management demands dynamic, real-time clinical decision-making—something current static protocols struggle to deliver. Strive fills this critical gap with a reinforcement learning platform that leverages over 10 million hours of ICU data to provide continuous, personalized dosing recommendations. This data-driven approach enhances patient outcomes by reducing complications and improving treatment precision in critical care settings.

As the healthcare landscape shifts toward precision medicine, Strive’s innovative technology is set to redefine clinical decision support in high-stakes environments. With strong early validation, strategic partnerships with key industry players, and a clear regulatory pathway, we are confident in Strive’s scalable growth and transformative potential.